• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中的物质滥用与认知功能

Substance abuse and cognitive functioning in schizophrenia.

作者信息

Addington J, Addington D

机构信息

Department of Psychiatry, University of Calgary, Alberta, Canada.

出版信息

J Psychiatry Neurosci. 1997 Mar;22(2):99-104.

PMID:9074303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1188831/
Abstract

Individuals with schizophrenia have an increased vulnerability to abuse drugs or alcohol. This vulnerability can interfere with the course and treatment of the disorder and may also have a detrimental effect on already compromised cognitive functioning. This study has a matched, cross-sectional design and compares the social and cognitive functioning and the symptoms of 33 schizophrenia subjects who abuse substances with 33 nonabusing schizophrenia subjects. Subjects were matched on sex, age, and education variables and were all outpatients. Measures of social functioning and quality of life were used. Assessment of cognitive functioning included measures of verbal ability, attention, executive functioning, and verbal and visual memory. Substance-abusing subjects had significantly lower quality of life. There were no other differences between the 2 groups. Several explanations are offered for the lack of observed differences in cognitive functioning.

摘要

精神分裂症患者滥用药物或酒精的易感性增加。这种易感性会干扰该疾病的病程和治疗,还可能对本已受损的认知功能产生不利影响。本研究采用匹配的横断面设计,比较了33名滥用物质的精神分裂症患者和33名不滥用物质的精神分裂症患者的社会和认知功能以及症状。受试者在性别、年龄和教育变量上进行了匹配,均为门诊患者。使用了社会功能和生活质量的测量方法。认知功能评估包括语言能力、注意力、执行功能以及语言和视觉记忆的测量。滥用物质的受试者生活质量显著较低。两组之间没有其他差异。针对在认知功能方面未观察到差异的情况给出了几种解释。

相似文献

1
Substance abuse and cognitive functioning in schizophrenia.精神分裂症中的物质滥用与认知功能
J Psychiatry Neurosci. 1997 Mar;22(2):99-104.
2
Comorbidity: A sign of the times.共病:时代的标志。
J Psychiatry Neurosci. 1997 Mar;22(2):97-8.
3
Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.精神分裂症和物质使用障碍患者的工作记忆与抑郁症状
Cogn Neuropsychiatry. 2008 Jul;13(4):357-66. doi: 10.1080/13546800802264330.
4
Substance use and cognition in early psychosis.早期精神病中的物质使用与认知
J Psychiatry Neurosci. 2003 Jan;28(1):48-54.
5
Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.精神分裂症中认知缺陷、症状与生活质量之间的关系。
Aust N Z J Psychiatry. 2008 Jun;42(6):496-504. doi: 10.1080/00048670802050512.
6
Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.精神分裂症患者的创伤后应激障碍、认知功能与生活质量
Psychiatry Res. 2008 May 30;159(1-2):140-6. doi: 10.1016/j.psychres.2007.10.012. Epub 2008 Apr 21.
7
[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].[共病物质使用对患有精神病性或心境障碍的受试者神经心理表现的影响]
Encephale. 2002 Mar-Apr;28(2):160-8.
8
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
9
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.快感缺失和社会适应能力可预测双相诊断精神分裂症患者的物质滥用演变情况。
Am J Drug Alcohol Abuse. 2008;34(1):75-82. doi: 10.1080/00952990701764631.
10
Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.患有酒精中毒和精神分裂症的双重诊断中年及老年患者的神经认知功能
Int J Geriatr Psychiatry. 2006 Aug;21(8):711-8. doi: 10.1002/gps.1528.

引用本文的文献

1
Integrative Roles of Dopamine Pathway and Calcium Channels Reveal a Link between Schizophrenia and Opioid Use Disorder.多巴胺通路与钙通道的综合作用揭示了精神分裂症与阿片类药物使用障碍之间的联系。
Int J Mol Sci. 2023 Feb 17;24(4):4088. doi: 10.3390/ijms24044088.
2
Metaphor Processing Dysfunctions in Schizophrenia Patients With and Without Substance Use Disorders.有和无物质使用障碍的精神分裂症患者的隐喻加工功能障碍
Front Psychiatry. 2020 Apr 24;11:331. doi: 10.3389/fpsyt.2020.00331. eCollection 2020.
3
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.大麻致非情感性精神病的途径可能反映出较低的神经生物学易损性。
Front Psychiatry. 2014 Nov 18;5:159. doi: 10.3389/fpsyt.2014.00159. eCollection 2014.
4
BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA.简要报告:酒精和大麻滥用对精神分裂症患者认知的影响
Schizophr Res Cogn. 2014 Sep 1;1(3):160-163. doi: 10.1016/j.scog.2014.08.001.
5
An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia.一项 fMRI 研究探讨了物质滥用史对精神分裂症患者工作记忆相关脑激活的影响。
Front Psychiatry. 2014 Jan 21;5:1. doi: 10.3389/fpsyt.2014.00001. eCollection 2014.
6
Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.精神分裂症患者的神经认知功能:使用药物与未使用药物的情况
Schizophr Bull. 2014 Jul;40(4):856-67. doi: 10.1093/schbul/sbt099. Epub 2013 Jul 24.
7
Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis.在使用大麻的戒断精神分裂症患者中,在某些神经心理学测试上表现较差。
Med Sci Monit. 2012 Sep;18(9):CR581-6. doi: 10.12659/msm.883355.
8
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.精神分裂症和物质使用障碍患者物质使用、神经和精神症状的演变:一项使用喹硫平的为期12周的先导性病例对照试验。
Front Psychiatry. 2011 May 13;2:22. doi: 10.3389/fpsyt.2011.00022. eCollection 2011.
9
The relationship between eating disorder psychopathology and health-related quality of life within a community sample.在社区样本中,饮食障碍心理病理学与健康相关生活质量之间的关系。
Qual Life Res. 2011 Jun;20(5):675-82. doi: 10.1007/s11136-010-9799-x. Epub 2010 Nov 20.
10
Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.共病心境障碍、精神病和大麻滥用障碍:理论综述。
J Addict Dis. 2009 Oct;28(4):309-19. doi: 10.1080/10550880903182960.

本文引用的文献

1
Substance abuse in schizophrenia: service utilization and costs.精神分裂症中的物质滥用:服务利用与成本
J Nerv Ment Dis. 1993 Apr;181(4):227-32. doi: 10.1097/00005053-199304000-00003.
2
Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age.18至35岁戒酒者的神经心理功能
Am J Psychiatry. 1995 Jan;152(1):53-9. doi: 10.1176/ajp.152.1.53.
3
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.生活质量量表:一种用于评估精神分裂症缺陷综合征的工具。
Schizophr Bull. 1984;10(3):388-98. doi: 10.1093/schbul/10.3.388.
4
The positive and negative syndrome scale (PANSS) for schizophrenia.精神分裂症的阳性与阴性症状量表(PANSS)
Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.
5
Treatment outcome of first episode schizophrenia.首发精神分裂症的治疗结果
Psychopharmacol Bull. 1989;25(1):92-6.
6
Alcohol use and abuse in schizophrenia. A prospective community study.精神分裂症中的酒精使用与滥用。一项前瞻性社区研究。
J Nerv Ment Dis. 1989 Jul;177(7):408-14. doi: 10.1097/00005053-198907000-00004.
7
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.精神分裂症中物质滥用的患病率:人口统计学和临床相关性。
Schizophr Bull. 1990;16(1):31-56. doi: 10.1093/schbul/16.1.31.
8
The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients.社会功能量表。一种用于精神分裂症患者家庭干预项目的新型社会适应量表的编制与验证。
Br J Psychiatry. 1990 Dec;157:853-9. doi: 10.1192/bjp.157.6.853.
9
Significance of cocaine history in schizophrenia.可卡因使用史在精神分裂症中的意义。
J Nerv Ment Dis. 1990 Oct;178(10):642-8. doi: 10.1097/00005053-199010000-00005.
10
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.精神分裂症患者的药物滥用:临床关联及使用原因
Am J Psychiatry. 1991 Feb;148(2):224-30. doi: 10.1176/ajp.148.2.224.